{
  "chapter": "Antimicrobials-Properties Of Anti-Microbial Agents",
  "questions": [
    {
      "q_no": 1,
      "question": "A 30-year-old male patient presents with a fever and signs of acute hemolytic anemia. He has a medical history significant for glucose-6-phosphate dehydrogenase (G6PD) deficiency. Laboratory investigations reveal hemoglobinuria and a decreased hemoglobin level. The patient is diagnosed with a hemolytic crisis secondary to G6PD deficiency. Which of the following antibiotics is safest to administer to this patient?",
      "options": {
        "A": "Ciprofloxacin",
        "B": "Azithromycin",
        "C": "Metronidazole",
        "D": "Nitrofurantoin"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Azithromycin Explanation: Among the listed antibiotics, azithromycin , a macrolide , is generally considered safe for patients with G6PD deficiency. Safe in G6PD deficiency Unsafe in G6PD deficiency Mnemonic: PCM P enicillins C ephalosporins M acrolides (Option B) M efloquine Mnemonic: MAD FAN Can M etronidazole (Option C ruled out) A ntimalarials- except mefloquine D apsone F luoroquinolones (Option A ruled out) A spirin N itro drugs- Nitrofurantoin (Option D ruled out) C hloramphenicol Reference: Drugs Official List Blood Disorder Treatment in Indiana | Innovative Hematology, Inc. Dexmedetomidine-based intravenous anesthesia of a pediatric patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency: A case report",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    },
    {
      "q_no": 2,
      "question": "A 28-year-old pregnant woman at 32 weeks gestation presents with symptoms suggestive of a urinary tract infection (UTI). She has a past medical history of penicillin allergy but is otherwise healthy. Considering her pregnancy status, which of the following antibiotics would be contraindicated due to potential adverse effects on the fetus?",
      "options": {
        "A": "Erythromycin",
        "B": "Cephalexin",
        "C": "Amoxicillin",
        "D": "Ciprofloxacin"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Ciprofloxacin Explanation: Ciprofloxacin (fluoroquinolone) is contraindicated in pregnancy due to its association with potential adverse effects on fetal bone and cartilage. Erythromycin, Cephalexin, and Amoxicillin are generally considered safe to use in pregnancy and are commonly prescribed for the treatment of UTIs during pregnancy, with appropriate consideration of maternal and fetal factors. Safe in pregnancy Unsafe in pregnancy Mnemonic: PCM P enicillins (Option C ruled out) C ephalosporins ( Option B ruled out) M acrolides (Option A ruled out) M efloquine Mnemonic: FATS F luoroquinolones: Fetal bone and cartilage damage due to chelating effect (Option D) A minoglycosides: Ototoxic to the fetus T etracycline S ulphonamides: Fetal bone and cartilage damage due to chelating effect, kernicterus in 3rd trimester Reference: A Review of Antibiotic Use in Pregnancy - PubMed . Use of Antibiotic Treatment in Pregnancy and the Risk of Several Neonatal Outcomes: A Population-Based Study Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy - PubMed",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    },
    {
      "q_no": 3,
      "question": "Which of the following are not safe to use in severe renal disease?",
      "options": {
        "A": "Linezolid",
        "B": "Rifampicin",
        "C": "Tobramycin",
        "D": "Cefoperazone"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Tobramycin Explanation: Tobramycin (aminoglycoside) can pose risks in individuals with kidney disease due to its potential for nephrotoxicity. In people with compromised kidney function, tobramycin may not be effectively cleared from the body, leading to its accumulation and increased toxicity. Renal safe antibiotics Drugs that are excreted in bile are safe to use in renal disease (No dose reduction required) Mnemonic: Totally Contraindicated In RENAL Failure Disease T igecycline C efoperazone (Option D ruled out) I soniazid R ifampicin (Option B ruled out) E rythromycin N afcillin A zithromycin L inezolid (Option A ruled out) F luoroquinolones- Pefloxacin, Moxifloxacin, Trovafloxacin D oxycycline Reference: Clinical Pharmacology of Antibiotics : Clinical Journal of the American Society of Nephrology Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 1172",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    },
    {
      "q_no": 4,
      "question": "Which of the following statements regarding Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) accurately distinguishes bactericidal from bacteriostatic drugs?",
      "options": {
        "A": "Bactericidal drugs have a narrower range between MIC and MBC than bacteriostatic drugs",
        "B": "Bacteriostatic drugs show a higher MIC to MBC ratio than bactericidal drugs",
        "C": "Both drug types have similar MIC but different MBC values",
        "D": "Bactericidal drugs have higher MIC but lower MBC values than bacteriostatic drugs"
      },
      "correct_answer": "A",
      "explanation": "bacteriostatic drugs Correct Answer: A) Bactericidal drugs have a narrower range between MIC and MBC than bacteriostatic drugs Explanation: Bactericidal drugs often have a smaller difference between the MIC (the concentration required to inhibit bacterial growth) and MBC (the concentration required to kill bacteria) than bacteriostatic drugs. This indicates a more potent killing effect at concentrations close to those needed to inhibit growth. Bacteriostatic agents inhibit bacterial growth, typically measured by the Minimum Inhibitory Concentration (MIC), while bactericidal agents kill bacteria, usually measured by the Minimum Bactericidal Concentration (MBC). In other words, bacteriostatic prevents further growth, while bactericidal directly eliminates bacteria. Bacteriostatic Bactericidal MIC<<<MBC Bacterial growth is restricted but not killed The remaining bacteria are killed by the immunity of the body Examples- Tetracyclines, macrolides MIC = MBC Bacteria are completely killed Examples- Beta-lactams, Fluoroquinolones, aminoglycosides Reference: Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) for Twelve Antimicrobials (Biocides and Antibiotics) in Eight Strains of Listeria monocytogenes Following the Mechanisms of Bacteriostatic versus Bactericidal Action Using Raman Spectroscopy - PMC ). Pharmacokinetics and Pharmacodynamics of Antibacterial Agents - PMC .",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    },
    {
      "q_no": 5,
      "question": "What is the Post-Antibiotic Effect (PAE)?",
      "options": {
        "A": "The ability of antibiotics to continue killing bacteria post-administration",
        "B": "The period during which bacteria develop resistance post-antibiotic exposure",
        "C": "The ability of antibiotics to suppress bacterial growth beyond MIC",
        "D": "Extended inhibition of bacterial regrowth post-antibiotic clearance"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Extended inhibition of bacterial regrowth post-antibiotic clearance Explanation: The Post-Antibiotic Effect (PAE) refers to the continued suppression of bacterial growth or a delay in bacterial regrowth after a period of exposure to antibiotics, even after the drugs have been eliminated from the body. Concentration-dependent killing (CDK) Represents the dose of antimicrobials above MIC that can kill the microbe It is a single high-dose Examples- Aminoglycosides and metronidazole Time-dependent killing (TDK) Represents the duration over a longer period of time for antimicrobials to kill the bacteria It is multiple daily doses. Examples- Penicillin, Azithromycin CTDK (combination of CDK &TDK) CTDK is also known as area-dependent killing. Examples- Vancomycin, Fluoroquinolones Post Antibiotic Effect (PAE) Prolonged suppression of bacterial growth after antibiotic exposure, even when drug levels fall below MIC, due to the body's immune response. Advantage: Duration of therapy can be reduced. E.g. In TB, Rifampicin is given once a day due to its CDK property, but in leprosy, it is given once a month to utilise its PAE effectively. Reference: http://www.antimicrobe.org/history/PK-PD%20Quint.pdf Postantibiotic Effect and Postantibiotic Sub-MIC Effect of Levofloxacin Compared to Those of Ofloxacin, Ciprofloxacin, Erythromycin, Azithromycin, and Clarithromycin against 20 Pneumococci | Antimicrobial Agents and Chemotherapy The postantibiotic effect: a review of in vitro and in vivo data - PubMed",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Antimicrobials-Properties_Of_Anti-Microbial_Agents_Q5_exp.png",
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    },
    {
      "q_no": 6,
      "question": "Which statement is true about acquired resistance?",
      "options": {
        "A": "It depends on both the microorganism and the drug",
        "B": "It depends only on the microorganism",
        "C": "It depends only on the drug",
        "D": "It is independent of the microorganism and the drug"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) It depends on both the microorganism and the drug Explanation: Resistance is the unresponsiveness of a microorganism to an antimicrobial agent (AMA). It depends on both the microorganism and the drug. There are 2 types: Natural resistance Acquired resistance Some microbes lack the metabolic process or target site the particular drug affects Development of resistance by an organism (sensitive before) due to the use of an AMA over a period of time e.g. gram-negative bacilli are unaffected by penicillin G aerobic organisms are not affected by metronidazole anaerobic bacteria are not inhibited by aminoglycoside antibiotics The development of resistance is dependent on the microorganism as well as on the drug. Some bacteria rapidly acquire resistance, e.g. staphylococci, coliforms, tubercle bacilli, gonococci This does not pose a significant clinical problem This can happen with any microbe and is a major clinical problem They are of 2 types Mutation Gene transfer Reference: Essentials of Medical Pharmacology- K.D Tripathi, 8th Edition, Page 742",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    },
    {
      "q_no": 7,
      "question": "The transfer of antimicrobial resistance through a virus called bacteriophage is called?",
      "options": {
        "A": "Conjugation",
        "B": "Transduction",
        "C": "Transformation",
        "D": "Multistep mutation"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Transduction Explanation: Transduction is the transfer of a gene carrying antimicrobial resistance through the agency of a bacteriophage. It is a type of gene transfer. Mutation Gene transfer It is a stable and heritable genetic change that occurs spontaneously and randomly among microorganisms The gene that causes resistance is passed from one organism to another Vertical transfer of resistance; relatively slow and usually of lower grade Horizontal transfer of resistance; rapid spread; high-level resistance to several antibiotics There are 2 types Single step : A single gene mutation confers high resistance, emerging rapidly (e.g., enterococci to streptomycin) Multistep : Several gene modifications are involved; sensitivity decreases gradually stepwise. (e.g., resistance to erythromycin, tetracyclines and chloramphenicol) (Option D) There are 3 types Conjugation: One bacteria acquires a resistance gene from another bacteria via plasmid (e.g., MDR TB, typhoid) (Option A) Transduction: Bacteria acquire resistance genes from a bacteriophage (e.g., MRSA) Transformation -Bacteria acquire genes directly from the environment (e.g., pneumococci, gonococci) (Option C) TRANSDUCTION",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Antimicrobials-Properties_Of_Anti-Microbial_Agents_Q7_exp.jpg",
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    },
    {
      "q_no": 8,
      "question": "Bacteria lacking a cell wall, such as Mycoplasma species, primarily exhibit resistance through which mechanism?",
      "options": {
        "A": "Drug Efflux",
        "B": "Drug Influx",
        "C": "Enzyme Inactivation",
        "D": "Mutation in Target"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Drug Influx Explanation: Mycoplasma species, lacking a cell wall, resist antibiotics primarily by preventing the uptake of antimicrobial agents (AMAs) into the cell (Drug influx) There are 4 main causes of antimicrobial resistance. Description Examples Drug Efflux (Option A) Bacteria possess efflux pumps to expel toxic substances and antimicrobial agents (AMAs) Antimalarials (chloroquine), Tetracyclines, Tigecycline Drug Influx (Option B) Natural mechanisms in bacteria prevent the uptake of AMAs Mycoplasma (resistant to β -lactams and glycopeptides due to lack of cell wall) Enzyme inactivation (Option C) Bacterial enzymes like β -lactamases inactivate β -lactam drugs by hydrolysing a specific site in their ring structure β -lactams (penicillins, cephalosporins), Aminoglycosides, Chloramphenicol Mutation in target (Option D) Bacteria modify components of their cell to resist AMAs β -lactam resistance in gram-positive bacteria via altered penicillin-binding proteins (PBPs), Fluoroquinolones (DNA gyrase mutation), Vancomycin (van genes altering peptidoglycan precursors) Reference: An overview of the antimicrobial resistance mechanisms of bacteria - PMC .",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    },
    {
      "q_no": 9,
      "question": "When combining a bactericidal and bacteriostatic drug, what is the most likely outcome?",
      "options": {
        "A": "Drug antagonism",
        "B": "Drug synergism",
        "C": "Both Drug antagonism and drug synergism",
        "D": "Neither Drug antagonism nor drug synergism"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Drug antagonism Explanation: Drug synergism (Option B) Drug antagonism (Option A) Supra-additive effect when different antimicrobial agents (AMAs) are combined, enhancing efficacy beyond individual effects. Sequential enzyme block: E.g.,Sulfonamide + trimethoprim: Sequentially blocks bacterial folate metabolism, leading to cidal action together compared to static effects individually. Block drug inactivating enzyme: E.g., Ampicillin + Sulbactam: β -lactamases block ampicillin but sulbactam blocks β -lactamases. Increase entry of the drug into microbes: E.g., Cell wall synthesis inhibitors increase the entry of aminoglycosides (Ceftazidime enhances gentamicin penetration against Pseudomonas). When two AMAs belonging to different classes are used together, they sometimes have a negative effect on each other. Bactericidal + Bacteriostatic : Combining them may diminish the effect of bacteriostatic drugs. E.g., penicillin + tetracycline/chloramphenicol against pneumococci can increase mortality rates compared to penicillin alone. Penicillin can deactivate aminoglycosides when both are present together. Bacteria can produce beta-lactamases that degrade other beta-lactam antibiotics when used in combination. Reference: Essentials of Medical Pharmacology- K.D Tripathi, 8th Edition, Page 749-750",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Antimicrobials-Properties Of Anti-Microbial Agents"
    }
  ]
}
